Skip to main content

Table 1 Patient and fracture characteristics for all patients and for young and older

From: Patient-related outcome, fracture displacement and bone mineral density following distal radius fracture in young and older men

 

All

< 65 years

≥65 years

n = 133

n = 98

n = 35

Age at fracture (years)

54 ± 18 (21–88)

46 ± 14 (21–64)

75 ± 6 (67–88)

BMI (kg/m2)

26.0 ± 3.8 (16.0–40.8)

25.9 ± 3.8 (18.7–40.8)

26.1 ± 3.7 (16.0–31.2)

Charlson Comorbidity Index

1 ± 1 (0–6)

0 ± 1 (0–4)

2 ± 2 (0–6)

Smoking

 - current

22 (17%)

21 (21%)

1 (3%)

 - former

49 (37%)

27 (28%)

22 (63%)

Medication for osteoporosisc

6 (5%)

2 (2%)

4 (11%)

Trauma level - low

84 (63%)

53 (54%)

31 (89%)

Dominant hand fracture

51 (38%)

35 (36%)

16 (46%)

Fracture classification AO

 A

35 (26%)

21 (21%)

14 (40%)

 B

13 (19%)

12 (12%)

1 (3%)

 C

76 (57%)

57 (58%)

19 (56%)

Displacementb

 Initial

46 (39%)

31 (35%)

15 (50%)

 Follow-up

21 (23%)

7 (8%)

14 (41%)

Treatment

 Cast

68 (51%)

49 (50%)

19 (54%)

 Closed reduction & cast

31 (23%)

23 (23%)

8 (23%)

 Surgery

34 (26%)

26 (27%)

8 (23%)

BMD femoral neck (g/cm2)

0.929 ± 0.14 (0.57–1.27)

0.958 ± 0.14 (0.63–1.27)

0.851 ± 0.12 (0.53–1.10)

Osteoporosisa

24 (18%)

15 (15%)

9 (26%)

FRAXBMD (median, IQR)d

 10-year risk of MOF

6.6 (4.5;10)

5.0 (3.9;9.4)

8.8 (6.8;14.8)

 10-year risk of Hip fracture

1.6 (0.6;3.9)

0.7 (0.4;1.7)

3.6 (2;7.7)

  1. Age, height, weight, BMI and BMD are reported as mean (SD) and range; other parameters are reported as number (%), aT-score ≤ −2.5 at femoral neck, total hip or spine, bDisplacement: Dorsal tilt > 10° and/or ulnar variance > 2 mm °, cCalcium/Vitamin D, bisphosphonates, dFRAX calculated for cases from the age of 40 years. The total numbers may vary slightly because of missing data